Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trialEgbert F Smit,Enriqueta Felip,Dipesh Uprety,Misako Nagasaka,Kazuhiko Nakagawa,Luis Paz-Ares Rodríguez,Jose M Pacheco,Bob T Li,David Planchard,Christina Baik,Yasushi Goto,Haruyasu Murakami,Andreas Saltos, Kaline Pereira, Ayumi Taguchi,Yingkai Cheng, Qi Yan,Wenqin Feng,Zenta Tsuchihashi,Pasi A JänneThe Lancet Oncology（2024）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
